Cargando…
Meningioma recurrence
Meningioma accounts for more than 30% of all intracranial tumours. It affects mainly the elderly above the age of 60, at a female:male ratio of 3:2. The prognosis is variable: it is usually favourable with no progression in tumour grade and no recurrence in WHO grade 1 tumours. However, a minority o...
Autores principales: | Hortobágyi, Tibor, Bencze, János, Varkoly, Gréta, Kouhsari, Mahan C, Klekner, Álmos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter Open
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5329819/ https://www.ncbi.nlm.nih.gov/pubmed/28352788 http://dx.doi.org/10.1515/med-2016-0032 |
Ejemplares similares
-
Epigenetics of Meningiomas
por: Murnyák, Balázs, et al.
Publicado: (2015) -
Pathophysiology of Meningioma Growth in Pregnancy
por: Hortobágyi, Tibor, et al.
Publicado: (2017) -
PARP1 expression and its correlation with survival is tumour molecular subtype dependent in glioblastoma
por: Murnyák, Balázs, et al.
Publicado: (2017) -
Expression Pattern of Tenascin-C, Matrilin-2, and Aggrecan in Diseases Affecting the Corneal Endothelium
por: Varkoly, Gréta, et al.
Publicado: (2022) -
Extracellular matrix changes in corneal opacification vary depending on etiology
por: Módis, László V., et al.
Publicado: (2021)